Bcl-2 Polyclonal Antibody | BS65626

Bcl-2 Polyclonal Antibody | BS65626 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Mouse, Rat, (predicted: Human, )

Application: WB,IHC-P,

Application Range: WB=1:500-2000 

Background: The Bcl-2 gene was isolated at the chromosomal breakpoint of t (14;18) -bearing follicular B cell lymphomas (1,2) .Bcl-2 blocks cell death following a variety of stimuli and confers a death-sparing effect to certain hematopoietic cell lines following growth factor withdrawal (3,5) .Bcl-2 appears to function in several subcellular locations yet lacks any known motifs that would confer insight into its mechanism of action (6,7) .A more recently identified protein,designated Bax p21 (i.e., Bcl-associated X protein ),has extensive amino acid homology with Bcl-2 and both homodimerizes and forms heterodimers with Bcl-2 (8) . Overexpression of Bax accelerates apoptotic death induced by cytokine deprivation in an IL-3 dependent cell line and Bax also counters the death repressor activty of Bcl-2 (8) .

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: Bcl-2 Polyclonal Antibody detects endogenous levels of Bcl-2 protein.

Molecular Weight: 26 kD

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN.

Immunogen: KLH conjugated synthetic peptide derived from human Bcl-2

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: affinity purified by Protein A

Pathway: Examples of Crosstalk Between Post-translational Modifications,